• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

慢性阻塞性肺疾病中的血液和痰液嗜酸性粒细胞;与细菌载量的关系。

Blood and sputum eosinophils in COPD; relationship with bacterial load.

作者信息

Kolsum Umme, Donaldson Gavin C, Singh Richa, Barker Bethan L, Gupta Vandana, George Leena, Webb Adam J, Thurston Sarah, Brookes Anthony J, McHugh Timothy D, Wedzicha Jadwiga A, Brightling Christopher E, Singh Dave

机构信息

Division of Infection, Immunity and Respiratory Medicine, School of Biological Sciences, Faculty of Biology, Medicine and Health, Manchester Academic Health Science Centre, The University of Manchester and University Hospital of South Manchester NHS Foundation Trust, Manchester, M23 9QZ, UK.

The Medicines Evaluation Unit, Manchester, UK.

出版信息

Respir Res. 2017 May 8;18(1):88. doi: 10.1186/s12931-017-0570-5.

DOI:10.1186/s12931-017-0570-5
PMID:28482840
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5422866/
Abstract

BACKGROUND

Sputum and blood eosinophil counts predict corticosteroid effects in COPD patients. Bacterial infection causes increased airway neutrophilic inflammation. The relationship of eosinophil counts with airway bacterial load in COPD patients is uncertain. We tested the hypothesis that bacterial load and eosinophil counts are inversely related.

METHODS

COPD patients were seen at stable state and exacerbation onset. Sputum was processed for quantitative polymerase chain reaction detection of the potentially pathogenic microorganisms (PPM) H. influenzae, M. catarrhalis and S. pneumoniae. PPM positive was defined as total load ≥1 × 10copies/ml. Sputum and whole blood were analysed for differential cell counts.

RESULTS

At baseline, bacterial counts were not related to blood eosinophils, but sputum eosinophil % was significantly lower in patients with PPM positive compared to PPM negative samples (medians: 0.5% vs. 1.25% respectively, p = 0.01). Patients with PPM positive samples during an exacerbation had significantly lower blood eosinophil counts at exacerbation compared to baseline (medians: 0.17 × 10/L vs. 0.23 × 10/L respectively, p = 0.008), while no blood eosinophil change was observed with PPM negative samples.

CONCLUSIONS

These findings indicate an inverse relationship between bacterial infection and eosinophil counts. Bacterial infection may influence corticosteroid responsiveness by altering the profile of neutrophilic and eosinophilic inflammation.

摘要

背景

痰液和血液嗜酸性粒细胞计数可预测慢性阻塞性肺疾病(COPD)患者对皮质类固醇的反应。细菌感染会导致气道中性粒细胞炎症增加。COPD患者中嗜酸性粒细胞计数与气道细菌载量之间的关系尚不确定。我们检验了细菌载量与嗜酸性粒细胞计数呈负相关的假设。

方法

在稳定期和急性加重期对COPD患者进行观察。对痰液进行处理,用于定量聚合酶链反应检测潜在致病微生物(PPM)流感嗜血杆菌、卡他莫拉菌和肺炎链球菌。PPM阳性定义为总载量≥1×10拷贝/ml。对痰液和全血进行细胞分类计数分析。

结果

在基线时,细菌计数与血液嗜酸性粒细胞无关,但与PPM阴性样本相比,PPM阳性患者的痰液嗜酸性粒细胞百分比显著更低(中位数分别为0.5%和1.25%,p = 0.01)。急性加重期PPM阳性样本的患者在急性加重期时的血液嗜酸性粒细胞计数显著低于基线(中位数分别为0.17×10/L和0.23×10/L,p = 0.008),而PPM阴性样本未观察到血液嗜酸性粒细胞变化。

结论

这些发现表明细菌感染与嗜酸性粒细胞计数之间存在负相关。细菌感染可能通过改变中性粒细胞和嗜酸性粒细胞炎症特征来影响皮质类固醇反应性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/630d/5422866/9750026795f1/12931_2017_570_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/630d/5422866/7c9910e576b9/12931_2017_570_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/630d/5422866/d9632b3d153b/12931_2017_570_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/630d/5422866/7797a9dfd811/12931_2017_570_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/630d/5422866/2128ae3a1476/12931_2017_570_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/630d/5422866/620e070c59d9/12931_2017_570_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/630d/5422866/9750026795f1/12931_2017_570_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/630d/5422866/7c9910e576b9/12931_2017_570_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/630d/5422866/d9632b3d153b/12931_2017_570_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/630d/5422866/7797a9dfd811/12931_2017_570_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/630d/5422866/2128ae3a1476/12931_2017_570_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/630d/5422866/620e070c59d9/12931_2017_570_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/630d/5422866/9750026795f1/12931_2017_570_Fig6_HTML.jpg

相似文献

1
Blood and sputum eosinophils in COPD; relationship with bacterial load.慢性阻塞性肺疾病中的血液和痰液嗜酸性粒细胞;与细菌载量的关系。
Respir Res. 2017 May 8;18(1):88. doi: 10.1186/s12931-017-0570-5.
2
Peripheral blood eosinophils: a surrogate marker for airway eosinophilia in stable COPD.外周血嗜酸性粒细胞:稳定期慢性阻塞性肺疾病气道嗜酸性粒细胞增多的替代标志物。
Int J Chron Obstruct Pulmon Dis. 2016 Jul 1;11:1495-504. doi: 10.2147/COPD.S100338. eCollection 2016.
3
Association of sputum and blood eosinophil concentrations with clinical measures of COPD severity: an analysis of the SPIROMICS cohort.痰和血嗜酸性粒细胞浓度与 COPD 严重程度的临床指标的关联:SPIROMICS 队列分析。
Lancet Respir Med. 2017 Dec;5(12):956-967. doi: 10.1016/S2213-2600(17)30432-0. Epub 2017 Nov 13.
4
Bacteria and sputum inflammatory cell counts; a COPD cohort analysis.细菌和痰炎症细胞计数;COPD 队列分析。
Respir Res. 2020 Nov 1;21(1):289. doi: 10.1186/s12931-020-01552-4.
5
Association between pathogens detected using quantitative polymerase chain reaction with airway inflammation in COPD at stable state and exacerbations.使用定量聚合酶链反应检测到的病原体与慢性阻塞性肺疾病稳定期气道炎症及急性加重之间的关联。
Chest. 2015 Jan;147(1):46-55. doi: 10.1378/chest.14-0764.
6
Long-term effects of inhaled corticosteroids on sputum bacterial and viral loads in COPD.吸入皮质类固醇对 COPD 患者痰中细菌和病毒载量的长期影响。
Eur Respir J. 2017 Oct 5;50(4). doi: 10.1183/13993003.00451-2017. Print 2017 Oct.
7
Blood cell for the differentiation of airway inflammatory phenotypes in COPD exacerbations.在 COPD 加重期,用于气道炎症表型分化的血细胞。
BMC Pulm Med. 2020 Feb 24;20(1):50. doi: 10.1186/s12890-020-1086-1.
8
Airway bacteria measured by quantitative polymerase chain reaction and culture in patients with stable COPD: relationship with neutrophilic airway inflammation, exacerbation frequency, and lung function.通过定量聚合酶链反应和培养法测定稳定期慢性阻塞性肺疾病患者气道细菌:与中性粒细胞性气道炎症、急性加重频率及肺功能的关系
Int J Chron Obstruct Pulmon Dis. 2015 Jun 9;10:1075-83. doi: 10.2147/COPD.S80091. eCollection 2015.
9
Change in inflammation in out-patient COPD patients from stable phase to a subsequent exacerbation.门诊 COPD 患者从稳定期到随后加重期炎症变化。
Int J Chron Obstruct Pulmon Dis. 2009;4:101-9. doi: 10.2147/copd.s4854. Epub 2009 Apr 15.
10
Acute exacerbations of chronic obstructive pulmonary disease: identification of biologic clusters and their biomarkers.慢性阻塞性肺疾病急性加重:生物簇及其生物标志物的鉴定。
Am J Respir Crit Care Med. 2011 Sep 15;184(6):662-71. doi: 10.1164/rccm.201104-0597OC.

引用本文的文献

1
The Burden of COPD with Type 2 Inflammation in North-West Continental Europe.西北欧地区2型炎症相关慢性阻塞性肺疾病的负担
Int J Chron Obstruct Pulmon Dis. 2025 Aug 7;20:2767-2785. doi: 10.2147/COPD.S523371. eCollection 2025.
2
Chronic Obstructive Pulmonary Disease (COPD): Developments in Pharmacological Treatments.慢性阻塞性肺疾病(COPD):药物治疗的进展
Drugs. 2025 May 20. doi: 10.1007/s40265-025-02188-8.
3
Clinical Characteristics and Outcomes of Eosinophilic Exacerbations of COPD.慢性阻塞性肺疾病嗜酸性粒细胞性加重的临床特征与转归

本文引用的文献

1
Impaired anti-inflammatory action of glucocorticoid in neutrophil from patients with steroid-resistant asthma.糖皮质激素在激素抵抗型哮喘患者中性粒细胞中的抗炎作用受损。
Respir Res. 2016 Nov 16;17(1):153. doi: 10.1186/s12931-016-0462-0.
2
Effect of inhaled corticosteroids on blood eosinophil count in steroid-naïve patients with COPD.吸入性皮质类固醇对初治 COPD 患者血嗜酸性粒细胞计数的影响。
BMJ Open Respir Res. 2016 Sep 8;3(1):e000151. doi: 10.1136/bmjresp-2016-000151. eCollection 2016.
3
Current Controversies in the Pharmacological Treatment of Chronic Obstructive Pulmonary Disease.
Int J Chron Obstruct Pulmon Dis. 2025 Apr 13;20:1061-1070. doi: 10.2147/COPD.S485246. eCollection 2025.
4
Lung IL-13 gene signatures are associated with raised tissue eosinophils in COPD.肺部白细胞介素-13基因特征与慢性阻塞性肺疾病中组织嗜酸性粒细胞增多有关。
Respir Res. 2025 Mar 25;26(1):114. doi: 10.1186/s12931-025-03177-x.
5
Prognostic value of the platelet, neutrophil, monocyte, basophil, and eosinophil to lymphocyte ratios in patients with severe community-acquired pneumonia (SCAP).血小板、中性粒细胞、单核细胞、嗜碱性粒细胞及嗜酸性粒细胞与淋巴细胞比值在重症社区获得性肺炎(SCAP)患者中的预后价值
Sci Rep. 2024 Dec 6;14(1):30406. doi: 10.1038/s41598-024-80727-1.
6
Expression of human Interferon Regulatory Factor 3 (IRF-3) in alveolar macrophages relates to clinical and functional traits in COPD.人干扰素调节因子 3(IRF-3)在肺泡巨噬细胞中的表达与 COPD 的临床和功能特征相关。
Respir Res. 2024 Aug 19;25(1):315. doi: 10.1186/s12931-024-02952-6.
7
Sputum microbe community alterations induced by long-term inhaled corticosteroid use are associated with airway function in chronic obstructive pulmonary disease patients based on metagenomic next-generation sequencing (mNGS).基于宏基因组下一代测序(mNGS),长期使用吸入性糖皮质激素引起的痰液微生物群落改变与慢性阻塞性肺疾病患者的气道功能相关。
Front Pharmacol. 2024 Jun 10;15:1323613. doi: 10.3389/fphar.2024.1323613. eCollection 2024.
8
High Blood Eosinophil Count at Stable State is Not Associated with Airway Microbiota Distinct Profile in COPD.稳定期高血嗜酸性粒细胞计数与 COPD 患者气道微生物群特征无明显相关性。
Int J Chron Obstruct Pulmon Dis. 2024 Mar 18;19:765-771. doi: 10.2147/COPD.S453526. eCollection 2024.
9
Blood Eosinophil Count and Its Determinants in a Chinese Population-Based Cohort.基于人群的中国队列研究中血嗜酸性粒细胞计数及其影响因素。
Respiration. 2024;103(2):70-78. doi: 10.1159/000535989. Epub 2024 Jan 22.
10
Blood eosinophils in chronic obstructive pulmonary disease: A potential biomarker.慢性阻塞性肺疾病中的血液嗜酸性粒细胞:一种潜在的生物标志物。
J Transl Int Med. 2023 Sep 2;11(3):193-197. doi: 10.2478/jtim-2023-0096. eCollection 2023 Sep.
慢性阻塞性肺疾病药理学治疗的当前争议。
Am J Respir Crit Care Med. 2016 Sep 1;194(5):541-9. doi: 10.1164/rccm.201606-1179PP.
4
Peripheral blood eosinophils: a surrogate marker for airway eosinophilia in stable COPD.外周血嗜酸性粒细胞:稳定期慢性阻塞性肺疾病气道嗜酸性粒细胞增多的替代标志物。
Int J Chron Obstruct Pulmon Dis. 2016 Jul 1;11:1495-504. doi: 10.2147/COPD.S100338. eCollection 2016.
5
Blood eosinophils and treatment response in hospitalized exacerbations of chronic obstructive pulmonary disease: A case-control study.慢性阻塞性肺疾病住院加重期血液嗜酸性粒细胞与治疗反应:一项病例对照研究。
Pulm Pharmacol Ther. 2016 Apr;37:89-94. doi: 10.1016/j.pupt.2016.03.004. Epub 2016 Mar 18.
6
Blood Eosinophils and Outcomes in Severe Hospitalized Exacerbations of COPD.血液嗜酸性粒细胞与 COPD 严重住院加重期的结局。
Chest. 2016 Aug;150(2):320-8. doi: 10.1016/j.chest.2016.01.026. Epub 2016 Feb 3.
7
Blood eosinophil count to predict bronchial eosinophilic inflammation in COPD.血液嗜酸性粒细胞计数预测慢性阻塞性肺疾病中的支气管嗜酸性粒细胞炎症。
Eur Respir J. 2016 May;47(5):1562-4. doi: 10.1183/13993003.01659-2015. Epub 2016 Feb 4.
8
Blood eosinophils and inhaled corticosteroid/long-acting β-2 agonist efficacy in COPD.血液嗜酸性粒细胞与慢性阻塞性肺疾病中吸入性糖皮质激素/长效β-2受体激动剂的疗效
Thorax. 2016 Feb;71(2):118-25. doi: 10.1136/thoraxjnl-2015-207021. Epub 2015 Nov 19.
9
Oral and inhaled p38 MAPK inhibitors: effects on inhaled LPS challenge in healthy subjects.口服和吸入性p38丝裂原活化蛋白激酶抑制剂:对健康受试者吸入脂多糖激发试验的影响。
Eur J Clin Pharmacol. 2015 Oct;71(10):1175-84. doi: 10.1007/s00228-015-1920-1. Epub 2015 Aug 13.
10
Airway bacteria measured by quantitative polymerase chain reaction and culture in patients with stable COPD: relationship with neutrophilic airway inflammation, exacerbation frequency, and lung function.通过定量聚合酶链反应和培养法测定稳定期慢性阻塞性肺疾病患者气道细菌:与中性粒细胞性气道炎症、急性加重频率及肺功能的关系
Int J Chron Obstruct Pulmon Dis. 2015 Jun 9;10:1075-83. doi: 10.2147/COPD.S80091. eCollection 2015.